Zkusit zdarma
Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Cena:
 
 
Valuace
70
Růst
53
Zdraví
75
preloader

Finanční výsledky Relmada Therapeutics, Inc. (RLMD)

Měna: USD

Ukazatel20252024202320222021
Diluted EPS-1.45-2.65-3.28-5.3-7.16
Gross Profit-----
Net Income Attributable to Common Shareholders-57.4M-80M-98.8M-157M-125.8M
Operating Profit-59.1M-83.9M-103.7M-161.2M-125.7M
Total Revenues-----